Did anyone catch the term in SC Health’s new SPAC filing on Friday? If you didn’t, SC Health added an interesting twist for warrant holders. Essentially, this SPAC will be backstopping the warrants at $1.00 in the event of a liquidation. PLUS, they’re giving all public warrant holders the right to require the Sponsors to repurchase their warrants at a $1.00, even if the combination is approved. (Update: Pure Acquisition Corp. (PACQ) used this as well)
Per the prospectus: “Each holder of public warrants (other than our sponsor and its affiliates) will have the right to require our sponsor to repurchase or cause one of its affiliates to repurchase, at $1.00 per public warrant, our outstanding public warrants in connection with the completion of our business combination. If we are unable to close our business combination within the allotted time, our sponsor will purchase or cause an affiliate to purchase any outstanding public warrants for $1.00 per public warrant at the same time as we redeem our public shares.”
This means that on a $10.00 unit purchase at IPO, rather than being assured you will at least get back just $10.00 on your investment for just the share, your now going to be made whole at $10.50 for both the share and warrant, in a worst case scenario. (Remember, SC Health is offering a 1/2 warrant in their unit).
However, let’s assume an investor has made a $10 million purchase at IPO, or 1,000,000 units, and the current per-share redemption price is $10.25. Regardless of whether the SPAC combines or liquidates at that point, your initial $10 million purchase is now worth $10,750,000 if you redeem the share and the warrant is repurchased.
This warrant backstop is a BIG commitment on the part of the Sponsors since it’s potentially a $7.5 million repurchase. Remember, it’s not the target company that will be doing the repurchase of warrants, but as the prospectus states, it’s the Sponsor who is on the hook. That’s a lot of skin in the game.


Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...
At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...